AI-GPE Lab中文
Data[PhysioNet](https://physionet.org/)

Safety and Preliminary Efficacy of Intranasal Insulin for Cognitive Impairment in Parkinson Disease and Multiple System Atrophy

Abstract

This dataset was collected as part of a study that aimed to determine the effects of intranasal insulin (INI) on cognition and motor performance in PD. The study was a proof of concept, randomized, double-blinded, placebo-controlled trial evaluating the effects of 40 international units (IU) of insulin or saline once daily for four weeks on cognitive and functional performance. Of 16 subjects enrolled, eight in the INI group and six in the placebo group completed verbal fluency (FAS), Unified Parkinson Disease Scale (UPDRS), and modified Hoehn and Yahr scale (HY, PD severity) at baseline and post-treatment and were included in the analyses.

Catalogue metadata

Record ID
AISLI-R-1230564901CD3ACDECE0
Type
Data
Source catalogue
registry.opendata.aws
Topic
生命科学与生物医学
Use conditions
Open Data Commons Attribution License v1.0